Smith & Nephew announced Namal Nawana will step down as CEO on Oct. 31, 2019, according to a press release.
Roland Diggelmann has been appointed the new CEO and will begin his position on Nov. 1, 2019. According to the release, Diggelmann joined Smith & Nephew’s board in March 2018 as non-executive director. Prior to Smith & Nephew, he was CEO of Roche Diagnostics.
"On behalf of the board, I am delighted to welcome Roland Diggelmann as Smith & Nephew's incoming CEO,” Roberto Quarta, chair of Smith & Nephew, said, “I am certain that Roland's leadership qualities, combined with his excellent track record of delivering results in an innovation-led business, his deep expertise in the medical devices industry, and his knowledge of Smith & Nephew, make him the right person to build on the company's success into the future.”
He added, “During his time with Smith& Nephew, Namal has substantially transformed the business with a new strategy, purpose and culture, and renewed commitment to innovation, returning it to an improved growth trajectory. I would like to thank Namal for his leadership and many contributions to the company, our employees, customers and stakeholders.”